West Pharmaceutical Services Inc. (WST) Has Another Very Strong Trading Session

September 17, 2017 - By Michael Collier

Investors sentiment decreased to 0.96 in 2016 Q4. Its down 0.05, from 1.01 in 2016Q3. It dived, as 31 investors sold West Pharmaceutical Services Inc. shares while 97 reduced holdings. 45 funds opened positions while 78 raised stakes. 66.40 million shares or 1.35% more from 65.52 million shares in 2016Q3 were reported.
California State Teachers Retirement Systems holds 0.03% or 149,134 shares in its portfolio. Raymond James & has 0.01% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 63,225 shares. Jennison Limited Liability Company accumulated 0.05% or 480,136 shares. 814,014 are held by State Bank Of Ny Mellon Corporation. Tiaa Cref Inv Management Limited Company invested 0.02% in West Pharmaceutical Services Inc. (NYSE:WST). Kalmar Invs Inc De holds 695,976 shares. Moreover, Stifel Fin has 0.03% invested in West Pharmaceutical Services Inc. (NYSE:WST) for 85,631 shares. Emerald Advisers Inc Pa stated it has 14,493 shares or 0.05% of all its holdings. Wellington Shields And Limited reported 0.18% of its portfolio in West Pharmaceutical Services Inc. (NYSE:WST). Barclays Public Limited Company owns 7,327 shares. 41,588 are held by Irving Magee Inv. Paradigm Asset Mgmt Limited Liability Company owns 1,700 shares for 0% of their portfolio. Sei Invs holds 0% in West Pharmaceutical Services Inc. (NYSE:WST) or 50 shares. Nationwide Fund Advisors stated it has 245,701 shares. Ameriprise Fincl accumulated 390,531 shares.

Since May 2, 2017, it had 0 insider buys, and 2 insider sales for $5.63 million activity. 4,124 shares valued at $384,816 were sold by Malone Daniel on Tuesday, May 2.

The stock of West Pharmaceutical Services Inc. (NYSE:WST) is a huge mover today! The stock increased 4.59% or $4.21 on September 15, reaching $95.91. About 761,446 shares traded or 112.33% up from the average. West Pharmaceutical Services Inc. (NYSE:WST) has risen 33.75% since September 17, 2016 and is uptrending. It has outperformed by 17.05% the S&P500.
The move comes after 8 months positive chart setup for the $7.10B company. It was reported on Sep, 17 by Barchart.com. We have $102.62 PT which if reached, will make NYSE:WST worth $497.00M more.

Investors wait West Pharmaceutical Services Inc. (NYSE:WST) to report on October, 26. its quarterly earnings Wall Street analysts expect $0.53 earnings per share, $0.00 or 0.00 % from last year’s $0.53 same quarter earnings. This translates into $39.23 million profit for WST giving the stock a 45.24 P/E. This is assuming the current $0.53 EPS is accurate. West Pharmaceutical Services Inc.’s Wall Street analysts see 3.92 % EPS growth, taking into account the $0.51 EPS reproted in the previous quarter,

West Pharmaceutical Services Inc. (NYSE:WST) Ratings Coverage

Among 3 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. West Pharmaceutical Services had 10 analyst reports since August 4, 2015 according to SRatingsIntel. Wells Fargo downgraded West Pharmaceutical Services Inc. (NYSE:WST) on Wednesday, September 21 to “Market Perform” rating. Jefferies upgraded West Pharmaceutical Services Inc. (NYSE:WST) on Friday, September 15 to “Buy” rating. The firm earned “Outperform” rating on Friday, October 28 by Wells Fargo. The firm earned “Buy” rating on Friday, January 8 by Janney Capital. The rating was maintained by Jefferies with “Hold” on Monday, September 11. The stock of West Pharmaceutical Services Inc. (NYSE:WST) has “Hold” rating given on Tuesday, June 6 by Jefferies. The rating was maintained by Jefferies on Thursday, June 29 with “Hold”. Jefferies maintained the shares of WST in report on Thursday, July 27 with “Hold” rating. The stock of West Pharmaceutical Services Inc. (NYSE:WST) earned “Hold” rating by Zacks on Tuesday, August 4. The stock has “Outperform” rating by Wells Fargo on Tuesday, March 22.

More news for West Pharmaceutical Services Inc. (NYSE:WST) were recently published by: Nasdaq.com, which released: “West Pharmaceutical Services (WST) Shares Cross Above 200 DMA” on September 01, 2017. Prnewswire.com‘s article titled: “West Announces Fall Investor Conference Schedule” and published on August 25, 2017 is yet another important article.

West Pharmaceutical Services, Inc. is a maker of packaging components and delivery systems for injectable drugs and healthcare products. The company has market cap of $7.10 billion. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. It has a 40.96 P/E ratio. The Company’s divisions include Proprietary Products and Contract-Manufactured Products.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.